Introduction
SNX1, a member of a large family of hydrophilic proteins, interacts with various receptor types involved in intracellular trafficking. Both SNX1 and its splice variant, SNX1A, bind to the epidermal growth factor receptor (EGFR), facilitating its transportation to the lysosome for degradation. SNX1 exhibits an association with cellular membranes and interacts with epidermal growth factor (EGF), platelet-derived growth factor (PDGF), and receptor tyrosine kinases.
Description
Recombinant human SNX1, expressed in E. coli, is a non-glycosylated polypeptide chain comprising 415 amino acids (146-522 a.a.). With a molecular weight of 48 kDa, it consists of SNX1 fused to a 38 a.a. His-Tag at its N-terminus. Purification is achieved using proprietary chromatographic methods.
Physical Appearance
A colorless solution that has undergone sterile filtration.
Formulation
The SNX1 solution, at a concentration of 0.25 mg/ml, is formulated in a buffer containing 20mM Tris-HCl (pH 8), 0.1M NaCl, 1mM DTT, and 10% glycerol.
Stability
While SNX1 remains stable at 4°C for up to one week, storage at temperatures below -18°C is recommended. For extended storage, the addition of a carrier protein (0.1% HSA or BSA) is advisable. Repeated freeze-thaw cycles should be avoided.
Purity
Purity exceeding 90.0% as assessed by SDS-PAGE.
Synonyms
HsT17379, SNX1A, Vps5.
Amino Acid Sequence
MRGSHHHHHH GMASMTGGQQ MGRDLYDDDD KDRWGGSMTV GITDPEKIGD GMNAYVAYKV TTQTSLPLFR SKQFAVKRRF SDFLGLYEKL
SEKHSQNGFI VPPPPEKSLI GMTKVKVGKE DSSSAEFLEK RRAALERYLQ RIVNHPTMLQ DPDVREFLEK EELPRAVGTQ TLSGAGLLKM
FNKATDAVSK MTIKMNESDI WFEEKLQEVE CEEQRLRKLH AVVETLVNHR KELALNTAQF AKSLAMLGSS EDNTALSRAL SQLAEVEEKI
EQLHQEQANN DFFLLAELLS DYIRLLAIVR AAFDQRMKTW QRWQDAQATL QKKREAEARL LWANKPDKLQ QAKDEILEWE SRVTQYERDF
ERISTVVRKE VIRFEKEKSK DFKNHVIKYL ETLLYSQQQL AKYWEAFLPE AKAIS.